Q2 2024 Holdings
Filed 2024-08-14 | 272 holdings | $17.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| US Foods Hldg Corp(USFD) | COM | 912008109 | $24.4M | 460,124 | 0.1% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $24.4M | 675,000 | 0.1% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $24.5M | 2,940,672 | 0.1% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $24.8M | 546,519 | 0.1% |
| Uber Technologies Inc | NOTE 12/1 | 90353TAJ9 | $25.3M | $23,500,000 | 0.1% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $25.3M | 741,049 | 0.1% |
| Insulet Corp(PODD) | COM | 45784P101 | $26.4M | 130,881 | 0.2% |
| Linde PLC(LIN) | SHS | G54950103 | $27.7M | 63,155 | 0.2% |
| Analog Devices Inc(ADI) | COM | 032654105 | $28.7M | 125,800 | 0.2% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $29.0M | 124,013 | 0.2% |
| S&P Global Inc(SPGI) | COM | 78409V104 | $29.4M | 65,833 | 0.2% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $29.8M | 678,169 | 0.2% |
| Nutanix Inc(NTNX) | CL A | 67059N108 | $30.3M | 533,300 | 0.2% |
| CG Oncology Inc(CGON) | COM | 156944100 | $30.5M | 967,055 | 0.2% |
| CRH PLC(CRH) | ORD | G25508105 | $30.7M | 409,473 | 0.2% |
| Interactive Brokers Group in(IBKR) | COM CL A | 45841N107 | $31.0M | 253,203 | 0.2% |
| Fidelity Natl Information SV(FIS) | COM | 31620M106 | $34.0M | 451,512 | 0.2% |
| Dexcom Inc(DXCM) | COM | 252131107 | $34.6M | 305,186 | 0.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $35.1M | 125,300 | 0.2% |
| Merit MED SYS Inc(MMSI) | COM | 589889104 | $35.5M | 412,765 | 0.2% |
| Brown & Brown Inc(BRO) | COM | 115236101 | $35.8M | 400,000 | 0.2% |
| First Amern Finl Corp(FAF) | COM | 31847R102 | $36.4M | 675,000 | 0.2% |
| RLI Corp(RLI) | COM | 749607107 | $36.6M | 260,000 | 0.2% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $36.6M | 1,354,505 | 0.2% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $36.6M | 1,744,857 | 0.2% |
| Springworks Therapeutics Inc | COM | 85205L107 | $37.7M | 1,000,000 | 0.2% |
| Intercontinental Exchange in(ICE) | COM | 45866F104 | $37.7M | 275,334 | 0.2% |
| Stryker Corporation(SYK) | COM | 863667101 | $38.4M | 112,801 | 0.2% |
| Icon PLC(ICLR) | SHS | G4705A100 | $38.4M | 122,572 | 0.2% |
| Kaspi KZ JSC(KSPI) | SPONSORED ADS | 48581R205 | $38.5M | 298,490 | 0.2% |
| Trupanion Inc(TRUP) | COM | 898202106 | $40.1M | 1,362,500 | 0.2% |
| SEA LTD(SE) | SPONSORD ADS | 81141R100 | $40.7M | 569,183 | 0.2% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $41.4M | 1,079,440 | 0.2% |
| Integer Hldgs Corp(ITGR) | COM | 45826H109 | $42.1M | 363,969 | 0.2% |
| Aflac Inc(AFL) | COM | 001055102 | $43.3M | 485,000 | 0.3% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $45.5M | 1,114,101 | 0.3% |
| JPMorgan Chase & Co.(JPM) | COM | 46625H100 | $46.9M | 231,980 | 0.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $47.0M | 610,599 | 0.3% |
| Globant S A(GLOB) | COM | L44385109 | $47.7M | 267,715 | 0.3% |
| Berkshire Hathaway Inc del(BRK/B) | CL B NEW | 084670702 | $49.4M | 121,488 | 0.3% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $51.9M | 1,940,510 | 0.3% |
| Hagerty Inc(HGTY) | CL A COM | 405166109 | $52.0M | 5,000,000 | 0.3% |
| Biogen Inc(BIIB) | COM | 09062X103 | $52.2M | 225,000 | 0.3% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $53.0M | 164,934 | 0.3% |
| Mastercard Incorporated(MA) | CL A | 57636Q104 | $53.0M | 120,122 | 0.3% |
| NU Hldgs LTD(NU) | ORD SHS CL A | G6683N103 | $53.5M | 4,148,172 | 0.3% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $55.2M | 321,792 | 0.3% |
| Elevance Health Inc(ELV) | COM | 036752103 | $56.5M | 104,295 | 0.3% |
| Visa Inc(V) | COM CL A | 92826C839 | $59.6M | 226,989 | 0.4% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $61.6M | 1,500,000 | 0.4% |